Who Paid My Doc
Craig Surman
Psychiatry Cambridge, MA Medical Doctor
NPI 1912969874 CMS profile 617065
185 Alewife Brook Pkwy, Ste 2000, Cambridge, MA 02138
General payments
$110,816
Research payments
$15,000
Ownership & investment interest
$0
Research they led as principal investigator
$617,720
Through program year 2023, Craig Surman of Cambridge, MA is reported in the CMS Open Payments database as having received $110,816 across 85 general payments and $15,000 in research payments paid to them. Separately, studies naming them as principal investigator received $617,720 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 98th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $13,706 | 16 | |
| 2022 | General | $5,651 | 6 | |
| 2022 | Research | $15,000 | 1 | |
| 2021 | General | $18,918 | 14 | |
| 2020 | General | $29,658 | 16 | |
| 2019 | General | $42,882 | 33 |
Beside peers
- Craig Surman
- Psychiatry median
- Middle half of Psychiatry
- National median
In program year 2025, general payments to Craig Surman were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.
Show as a table
| Year | Craig Surman | Psychiatry median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $42,882 | $184 | $59–$605 | $163 |
| 2020 | $29,658 | $119 | $36–$372 | $114 |
| 2021 | $18,918 | $143 | $43–$576 | $132 |
| 2022 | $5,651 | $153 | $50–$590 | $149 |
| 2023 | $13,706 | $170 | $56–$651 | $160 |
| 2024 | $0 | $179 | $57–$673 | $164 |
| 2025 | $0 | $180 | $58–$685 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
171
Drug cost
$22,013
Branded share of claims
65.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Methylphenidate Er Methylphenidate Hcl | Brand | 54 | $6,628 | |
| Adderall Xr Dextroamphetamine/Amphetamine | Brand | 19 | $5,855 | |
| Strattera Atomoxetine Hcl | Brand | 12 | $5,311 | |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | Brand | 27 | $3,472 | |
| Methylphenidate Hcl | Generic | 31 | $676 | |
| Clonazepam | Generic | 16 | $35 | |
| Lorazepam | Generic | 12 | $35 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 4 billing codesPaid by Medicare
$4,266
Medicare patients
15
Services billed
45
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Arthritis | 73% | |
| Diabetes | 0% | |
| Heart failure | 0% | |
| Atrial fibrillation | 0% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
86 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Psychiatry in Massachusetts
Related records
Psychiatry in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Psychiatry
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.